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Abstract A receptor binding assay based on the surface
plasmon resonance (SPR) biosensor technique was developed to
study the interaction between insulin-like growth factor-1
receptor (IGF-1R) and its intracellular substrate protein insulin
receptor substrate-1 (IRS-1). The sensor surface was modified
with anti-IGF-1R (K-subunit) monoclonal antibodies for the
capturing of the receptor-containing membrane fragments from
cell lysates. The IGF-1R was successfully immobilized on the
sensor surface with binding capability for its intracellular
substrates. SPR measurements showed that the tyrosine
phosphorylation of IGF-1R induced by its extracellular ligand
insulin-like growth factor-1 caused the receptor to bind with
IRS-1 10 times faster than the unactivated receptor. As a result,
the affinity constants of IRS-1 to phosphorylated and unpho-
sphorylated IGF-1R were (8.06 þ 5.18)U109 M31 and (9.81 þ
4.61)U108 M31, respectively. ß 2001 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
The function of insulin-like growth factor-1 (IGF-1) is real-
ized by binding of IGF-1 to insulin-like growth factor-1 re-
ceptor (IGF-1R) and inducing their intrinsic tyrosine kinase
activity and autophosphorylation. This autophosphorylation
of IGF-1R leads to tyrosine phosphorylation of cellular sub-
strates such as insulin receptor substrates and src homology 2/
K-collagen. The tyrosine-phosphorylated proteins in turn
complex with a variety of src homology 2 (SH2) domain-con-
taining proteins, and initiate speci¢c signal pathways (cf. re-
views [1^5]). To date, four members of the insulin receptor
substrate (IRS) family, IRS-1 [6,7], IRS-2 [8], IRS-3 [9] and
IRS-4 [10], have been identi¢ed, as characterized by their sim-
ilar structure and functions. Each of the IRS proteins consists
of an amino-terminal pleckstrin homology domain, a phos-
photyrosine binding domain and a large domain containing
many motifs for tyrosine phosphorylation and for binding of
SH2-containing proteins. IRS-1 was the ¢rst to be puri¢ed
and cloned among the IRS family of proteins [6,7]. A number
of studies have investigated the interaction between IGF-1R
and IRS-1 in vivo using yeast two hybridization and Western
blot techniques [11^17]. However, the e¡ect of receptor auto-
phosphorylation level on the a⁄nity of IRS-1 binding to IGF-
1R has not been examined. In addition, quantitative thermo-
dynamic and kinetic pro¢les of the binding interaction be-
tween IRS-1 and IGF-1R with or without ligand activation
have not been determined.
Biosensor technology based on the surface plasmon reso-
nance (SPR) technique has been used to measure the binding
kinetics between a biomolecule in solution and its binding
partner immobilized on a sensor surface in real time [18].
Applications of the SPR biosensor include the study of recep-
tor^ligand interactions, the formation of signaling complexes,
epitope mapping and protein^DNA binding [19^23]. SPR bio-
sensor has been used to study the a⁄nities and kinetics of
IGF-1 binding with the extracellular fragments of IGF-1R
proteins and with its binding proteins [24^27]. Recently an
SPR-based method was reported for determination of agonist
selectivity of insulin receptor, IRS-1 and its downstream tar-
get phosphatidylinositol 3-kinase [28]. This method is based
on the competitive binding between two peptide fragments of
the signaling molecules in solution and on sensor surface. In a
relevant study, an antibody-modi¢ed sensor surface was gen-
erated and used to capture the epidermal growth factor re-
ceptor from cell lysate directly for the binding study of the
receptor with its extracellular ligands [29].
Characterization of membrane receptors with their extracel-
lular ligands or intracellular docking proteins/substrates has
been limited by the lack of quantitative assays to obtain the
kinetic and thermodynamic parameters of these binding inter-
actions. In this study, an in vitro method for detecting IGF-
1R and its intracellular substrate IRS-1 interactions based on
the SPR biosensor technique was developed. The assay prin-
ciple is schematically shown in Fig. 1. The IGF-1R (Ab-1) was
chemically cross-linked on the sensor chip surface to capture
IGF-1R directly from cell lysate containing IGF-1R mem-
brane fractions. Because of the antibody bound speci¢cally
to the K-subunit of the receptor, the L-subunit of IGF-1R
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was exposed to the solution phase and available for binding
with IRS-1 at the sensor^liquid interface. Each step of the
binding assay, including the immobilization of antibody, cap-
turing of the receptor, and binding of IRS-1, could be con-
trolled and monitored by the SPR biosensor in real time.
Binding of IRS-1 to the immobilized IGF-1R at di¡erent lev-
els of tyrosine phosphorylation can be monitored directly by
the SPR biosensor to provide kinetic and thermodynamic in-
formation of the interaction.
2. Materials and methods
2.1. Materials
Sensor chips (CM5 research grade), HBS bu¡er (10 mM HEPES,
150 mM NaCl, 3.4 mM EDTA, 0.05% P20, pH 7.4), and the amine
coupling kit containing N-hydroxysuccinimide (NHS), N-ethyl-NP-(3-
diethylaminopropyl)carbodiimide (EDC), and ethanolamine hydro-
chloride were acquired from BIAcore AB (Uppsala, Sweden). IRS-1
was from Upstate Biotechnology Inc. (Lake Placid, NY, USA).
Mouse monoclonal antibody against the K-subunit of human IGF-
1R [IGF-1R (Ab-1)] was from Calbiochem-Novabiochem Inc. (Cam-
bridge, MA, USA). The IGF-1R (Ab-1) was generated from a fusion
FO myeloma cell clone KIR3 and has been shown to preferentially
bind to the K-subunit of IGF-1R [30]. Anti-IGF-1R (L-subunit) was
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA,
USA). Antibody against phosphotyrosine was obtained from New
England Biolabs Inc. (Beverly, MA, USA). Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM), fetal bovine serum (FBS) and a mixture of
10 000 U/ml penicillin and 10 000 Wg/ml streptomycin were obtained
from Life Technologies Inc. (Grand Island, NY, USA). Geneticin
(antibiotic G418) was from Sigma (St. Louis, MO, USA). All other
chemicals used were of analytical grade, and doubly distilled deion-
ized water was used in all experiments.
2.2. Cell lines
The NIH-3T3 cell line overexpressing IGF-1R was obtained from
Professor Derek LeRoith (National Institute of Diabetes and Diges-
tive and Kidney diseases, NIH, Bethesda, MA, USA). The cells were
maintained in DMEM supplemented with 10% FBS, 500 Wg/ml G-
418, 100 U/ml penicillin, and 100 Wg/ml streptomycin. Control NIH-
3T3 cell line was maintained in the same medium but without supple-
mentation with G-418. All cell lines were cultured in a humidi¢ed
atmosphere of 95% air and 5% of CO2 at 37‡C.
2.3. Immunoblotting of receptor autophosphorylation
The cells overexpressing IGF-1R were grown to con£uence in
100-mm plates and serum-starved overnight in DMEM without sup-
plementation with FBS. The cells were then incubated either with or
without IGF-1 (100 ng/ml) for 1 min at 37‡C. IGF-1R and its auto-
phosphorylation were determined by the immunoprecipitation and
immunoblotting method previously described [17].
2.4. SPR receptor binding assay
The membrane fraction of the receptor for the SPR assay was
prepared based on previously reported protocols [29]. Brie£y, the
NIH-3T3 cell line overexpressing IGF-1R was grown to con£uence
in 150-mm plates and incubated either with or without IGF-1 (100
ng/ml) for 1 min at 37‡C as described above. The cells were then
washed rapidly three times with chilled phosphate-bu¡ered saline
and then lysed with 0.6 ml extraction bu¡er (1% Triton X-100 in
20 mM HEPES, 150 mM NaCl, 1 mM EGTA, pH 7.4, with freshly
added phosphatase inhibitor sodium orthovanadate (¢nal concentra-
tion 1 mM), and protease inhibitors (¢nal concentration of 0.5 mM
phenylmethylsulfonyl £uoride, 1% of protease inhibitors stock solu-
tion (100U, 1 M bezaidine, 8% bacitracin, 6 Wg/ml aprotinin, 0.2 mM
pepstatin, 0.2 mM leupeptin)). The cells were scraped by a cell scraper
and collected in a microtube. The plates were then washed by addition
of 0.3 ml extraction bu¡er. The combined lysate was cleared at 4‡C by
sequential centrifugation at top speed for 15 min (GS-15R centrifuge,
Beckman) and at 70 000 rpm for 30 min (NV70 rotor, Beckman). The
supernatants containing the membrane fraction of the cell lysate were
used in subsequent experiments.
All SPR measurements were performed on the BIAcore1 X appa-
ratus (BIAcore AB, Uppsala, Sweden). The basic principle of the SPR
biosensor has been described in detail elsewhere [31^33]. In general,
the sensor system probed the refractive index changes in a £ow cell
due to the binding of molecules to an immobilized ligand. The change
in refractive index detected by the sensor was expressed as an arbi-
trary unit called the resonance unit (RU). The arbitrary resonance
units are plotted against time in real time by the BIAcore instrument
and the plot is called a sensorgram.
Immobilization of IGF-1R (Ab-1) was carried out by the standard
EDC/NHS chemical procedure. Equal volumes of 0.2 M NHS and 0.4
M EDC were mixed just before use and 35 Wl of the mixture was
injected over the CM5 sensor chip to activate the carboxymethylated
dextran hydrogel on the sensor surface. A 35-Wl solution of IGF-1R
(Ab-1) (20 Wg/ml in 10 mM sodium acetate, pH 4.5) was injected over
the activated surface, followed by a 35-Wl solution of 1 M ethanol-
amine hydrochloride to deactivate the remaining active carboxyl
groups. Immediately after the immobilization, a 15-Wl solution of
100 mM HCl was injected three times to remove any remaining
non-covalently bound proteins. This was followed by a 3-h wash
with HBS bu¡er. The above immobilization procedure was carried
out at 25‡C and at a constant £ow rate of 5 Wl/min using HBS bu¡er.
The antibody-immobilized chip was equilibrated with HBS bu¡er,
followed by the injection of 40 Wl of membrane fraction of the lysate
to capture IGF-1R from cell lysates. After lysate injection, the sensor
chip surface was washed with HPS bu¡er until a stable baseline was
reached. To determine the a⁄nity of IRS-1 to IGF-1R, 32 Wl of IRS-1
at di¡erent concentrations in HBS bu¡er (pH 7.4) was injected over
the receptor-immobilized sensor chip (association phase), followed by
a 10-min wash with HBS bu¡er (dissociation phase). The sensor sur-
face was then regenerated by one pulse of injection with 4 Wl of 10
mM NaOH and 0.5% SDS solution to remove the receptor. The
regenerated surface was used for another cycle of receptor capturing
and IRS-1 binding experiment. To correct for non-speci¢c binding
and bulk refractive index change, a control channel with only the
antibody immobilized on the sensor chip surface was used and run
simultaneously for each IRS-1 binding experiment. After subtracting
the sensorgram from the control channel, the binding of IRS-1 to the
captured IGF-1R was obtained. All SPR experiments were carried out
at 25‡C with a constant £ow rate of 8 Wl/min in HBS bu¡er, unless
otherwise speci¢ed.
2.5. Kinetic models and data analysis
The sensorgrams were analyzed using BIAevaluation1 Software
version 3.1. Several binding models including simple one-site, one-
site binding with mass transport limit, one-site with conformational
change, and two-site binding [34] were used to ¢t the IRS-1/IGF-1R
interaction data using both integrated rate equation and numerical
integration methods. The degree of randomness of the residual plot
and the reduced M2 value were used to assess the appropriateness of a
model to the sensor data. The simplest and the most appropriate
model for each binding interaction was used to derive the kinetic
parameters. In all cases, the one-site model seemed to be su⁄cient
in ¢tting the data (see Section 3). The respective rate equation can be
described as:
dAB
dt
 kaAB3kdAB 1
where [AB] is the concentration of the bound complex on the sensor
surface, [B] is the immobilized binding partner (ligand), [A] is the
concentration of the injected binding partner (analyte), and ka and
kd are the association rate constant and dissociation rate constant,
respectively.
Since the response on the sensorgram, R, is directly related to [AB],
the rate equation can be integrated to give:
For association : R  Reqf13exp3kaA  kdt3t0g 2
For dissociation : R  R0 exp3kdt3t0 3
where Req is the steady-state response level and R0 is the response at
the start of dissociation. It should be noted that the e¡ect of steric
interference and re-binding are ignored. The equilibrium a⁄nity con-
stant (KA) is calculated based on the ratio ka/kd. The rate constants
may be recovered by ¢tting the binding curves through non-linear
regression analysis of the integrated equations (Eqs. 2 and 3). The
mean values of the association rate constants and dissociation rate
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constants for the IRS-1 binding to IGF-1R with or without autophos-
phorylation were obtained from triplicate experiments for each con-
centration of IRS-1. P values were determined by an unpaired Stu-
dent’s t-test to compare the mean values; P6 0.1 was considered to be
statistically signi¢cant.
3. Results
IGF-1R was captured from the cell lysate directly without
the need for purifying the receptor protein. A typical sensor-
gram for the immobilization of the antibody is shown in Fig.
2. For all experiments, about 1800 RU of immobilized anti-
body was prepared for all capturing steps. The changes in
sensor signal RU correspond to approximately 1.8 ng/mm2
of antibodies immobilized, based on the estimation that
1000 RU equals 1 ng/mm2 of surface mass [35]. The captured
IGF-1R could not be washed away by HBS bu¡er but could
be completely washed away by the solution containing 10 mM
NaOH and 0.5% SDS. The regenerated antibody surface
could be reused for subsequent IGF-1R capturing.
The cell lysate containing IGF-1R in the Triton X-100 ex-
tract from the transfected mouse NIH-3T3 cell line overex-
pressing IGF-1R, or the lysate from the control NIH-3T3 cell
line, was injected over the antibody-modi¢ed sensor chip. It
was found that the amount of the captured receptor was com-
pletely dependent on the presence of the anti-IGF-1R anti-
body (Fig. 3). IGF-1R was only captured on the sensor chips
modi¢ed with the anti-IGF-1R (K-subunit) antibody. The
blank CM5 chip surface did not bind IGF-1R. The amount
of IGF-1R captured from NIH-3T3 cells overexpressing IGF-
1R was signi¢cantly greater than that from the control NIH-
3T3 cells (600 RU vs. 100 RU). It was reported that the NIH-
3T3 cells overexpressing IGF-1R contain about 1U106 recep-
tor molecules per cell [17,36]. NIH-3T3 cells overexpressing
IGF-1R contained more receptor molecules per cell than
NIH-3T3 cell, as con¢rmed by Western blot experiments
(Fig. 4a).
In order to study the e¡ect of IGF-1-induced autophos-
phorylation of IGF-1R on its binding to IRS-1, the cells over-
expressing IGF-1R were treated with overnight serum starva-
tion to eliminate the e¡ect of growth hormones in the culture
medium, followed by 100 ng/ml of IGF-1 for 1 min. The IGF-
1 treatment induced tyrosine phosphorylation of IGF-1R in
its L-subunits, while the untreated cells did not show tyrosine
phosphorylation in the L-subunits of IGF-1R (Fig. 4b). In
addition, immunoprecipitation detection demonstrated that
binding of anti-IGF-1R (K-subunit) antibody to IGF-1R in
vitro did not induce the autophosphorylation of IGF-1R.
After capturing IGF-1R from the cell lysate, the sensor
surface was washed with HPS bu¡er for at least 2 h at a
£ow rate of 8 Wl/min until reaching a stable baseline. In all
experiments, approximately 380 RU of IGF-1R was captured
on the sensor surface for IRS-1 binding. The cell lysate from
IGF-1-treated or untreated cells was injected over the anti-
body-modi¢ed sensor surface under identical conditions and
similar sensor responses were observed, indicating similar
amounts of IGF-1R were captured on the sensor surface. It
was shown that IGF-1 stimulation did not a¡ect the binding
ability of the K-subunits of IGF-1R with the speci¢c antibody.
The IRS-1 solution at di¡erent concentrations was injected
over the IGF-1R-modi¢ed surface for a period of 240 s, fol-
lowed by washing with HBS bu¡er, giving a complete associ-
ation and dissociation pro¢le of IRS-1 binding with IGF-1R
(Fig. 5). After the IRS-1 binding experiment, the surface was
regenerated with 4 Wl of a 10 mM NaOH/0.5% SDS solution
to remove the captured IGF-1R. After 2 h of equilibration
with HPS bu¡er, the baseline returned to the level before
capturing IGF-1R. The surface could be used to capture
IGF-1R again from the cell lysate and another cycle of
IRS-1 binding experiment performed. The antibody-coupling
sensor chip could be reused for 30 cycles.
The binding and dissociation of IRS-1 at di¡erent concen-
trations (38.2, 19.1, and 3.64 nM) with the immobilized IGF-
1R from IGF-1 activated and unactivated cells are shown in
Fig. 5a,b, respectively. With increasing IRS-1 concentration,
the SPR signal increases for both activated and unactivated
IGF-1R but to di¡erent extents. The experiments were re-
peated three times and the binding data were ¢tted with var-
Fig. 1. Principle for the SPR-based receptor binding assay. Step 1, the antibody IGF-1R (Ab-1) is immobilized on the surface of a CM5 chip
by standard EDC/NHS reaction. Step 2, the cell lysate obtained from cells incubated with (a) or without (b) 100 ng/ml of IGF-1 is passed
through the sensor surface and the IGF-1R is captured by the antibody. The (-p) represents the phosphorylated tyrosine group in the L-subunit
of IGF-1R. Step 3, di¡erent concentrations of IRS-1 are injected and bind with receptors on the sensor surface.
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ious kinetic models on both association and dissociation
curves simultaneously. The goodness of the ¢t was judged
by the reduced M2 values and residual error distributions.
The Langmuir binding model was found to be adequate to
describe the binding interactions between the receptor and
IRS-1. The curve ¢tting was not signi¢cantly improved using
more complex models, as judged by the reduced M2 values.
The ¢tted ka and kd values for each concentration of IRS-1
binding were averaged to give mean values of ka and kd for
three sets of experiments (Table 1). An unpaired Student’s t-
test was used to compare the mean values from the two con-
ditions. It was found that IRS-1 binds with IGF-1-activated
IGF-1R 10 times faster than with unactivated IGF-1R
(P6 0.1). The dissociation rate constants of the IRS-1/IGF-
1R complexes between the two states of the receptor did not
show a signi¢cant di¡erence (P = 0.8). The a⁄nity constants
of IRS-1 to phosphorylated and unphosphorylated IGF-1R
were (8.06 þ 5.18)U109 M31 and (9.81 þ 4.61)U108 M31 re-
spectively. The a⁄nity of IRS-1 to phosphorylated IGF-1R
was 10 times greater than that to unphosphorylated IGF-1R
(P6 0.1).
4. Discussion
An SPR-based receptor binding assay was developed that
can evaluate the binding characteristics of IRS-1 with IGF-1R
with and without IGF-1 stimulation. This is the ¢rst time a
quantitative kinetic and thermodynamic pro¢le was obtained
for the IRS-1/IGF-1R interaction. Our results have con¢rmed
that IGF-1 induces tyrosine phosphorylation of IGF-1R (Fig.
4). IGF-1 binding to the cysteine-rich domain in the extracel-
lular K-subunit of the receptor triggers autophosphorylation
of the L-subunits and stimulates the tyrosine kinase activity
[17,36]. Each L-subunit then transphosphorylates the other,
leading to phosphorylation of a number of tyrosine residues
in the carboxy-terminal domain of the L-subunit. Phosphory-
lation of these residues markedly increases the activity of the
kinase domain towards downstream substrates. Our results
show that in addition to the increase in IGF-1R kinase activ-
ity, the phosphorylated IGF-1R has a higher a⁄nity for its
downstream substrate protein IRS-1 than the unphosphory-
lated IGF-1R (Table 1). Therefore, the tyrosine phosphoryla-
tion of IGF-1R has two distinct, but related, outcomes.
Firstly, the tyrosine kinase activity of the receptor is en-
hanced, and secondly, the phosphorylated tyrosine residues
Fig. 4. a: Western blot of IGF-1R (L-subunit) from control NIH-
3T3 cells (lane 1) and NIH-3T3 cells overexpressing IGF-1R (lane
2). b: IGF-1 stimulation of IGF-1R autophosphorylation in intact
cell. The NIH-3T3 cells overexpressing IGF-1R were stimulated
with (+, lanes 1^3) or without (3, lanes 4^6) 100 ng/ml of IGF-1.
Lysates (500 Wl) were immunoprecipitated with anti-IGF-1R (K-sub-
unit) antibody (lanes 1, 3) or anti-IGF-1R (L-subunit) antibody
(lanes 2, 5). Lysates (10 Wl) were added in lanes 4 and 6. The tyro-
sine-phosphorylated proteins (Tyr(P)) were detected by anti-Tyr(P)
antibody as described in Section 2.
Fig. 3. Sensorgrams for the capturing of IGF-1R from the NIH-
3T3 cell line with or without overexpression of IGF-1R by the im-
mobilized anti-IGF-1R antibody. Step 1, injection of cell lysates
from the two cell lines over the sensor chip surface. Step 2, washing
the sensor chip with HBS bu¡er. Step 3, regeneration of the sensor
chip with a solution containing 10 mM NaOH and 0.5% of SDS.
(a1) Injection of cell lysate from the NIH-3T3 cells overexpressing
IGF-1R over the sensor chip immobilized with IGF-1R (Ab-1); (b1)
injection of cell lysate from the control NIH-3T3 cells over the sen-
sor chip immobilized with IGF-1R (Ab-1); (a2) injection of cell ly-
sate form the NIH-3T3 cells overexpressing IGF-1R over the sensor
chip without IGF-1R (Ab-1); (b2) injection of cell lysate from con-
trol NIH-3T3 cells over the sensor chip without IGF-1R (Ab-1).
Fig. 2. Real-time sensorgram for IGF-1R (Ab-1) immobilization on
SPR sensor surface. The sensor chip (CM5) was equilibrated with
HBS bu¡er (step 1). The carboxylated dextran layer was activated
by a solution of NHS and EDC (step 2). 35 Wl of 20 Wg/ml IGF-1R
(Ab-1) in 10 mM acetate bu¡er, pH 4.5, was then passed over the
surface for covalent coupling (step 3), and the residual coupling
groups were inactivated by ethanolamine (step 4). The surface was
washed by 100 mM HCl (step 5), followed by a 3-h wash with HBS
bu¡er. After the immobilization process, a net increase of 1800 RU
in SPR signal was observed which corresponds to a surface density
of approximately 1.8 ng/mm2 covalently bound IGF-1R (Ab-1).
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provide better binding sites for its substrate proteins that me-
diate the signaling cascades emanating from the IGF-1 recep-
tor.
Both IGF-1-activated and unactivated IGF-1R showed
high a⁄nity towards IRS-1, although the former binds to
IRS-1 with one order of magnitude greater a⁄nity. The in-
crease in the a⁄nity constant is mainly due to the increase in
the association rate constant of IRS-1 binding to activated
IGF-1R. The a⁄nity constant values suggest that the intra-
cellular concentration of IRS-1 should be in the range of
10^100 nM in order for the molecules to respond to the acti-
vation of the IGF-1R.
The observed binding a⁄nity of IRS-1 with unactivated
IGF-1R in our experiments may be explained by the IGF-1-
mimic e¡ect of the antibody KIR-3 we used. It was reported
that several monoclonal antibodies against IGF-1R weakly
stimulated DNA synthesis in IGF-1R/3T3 cells [37]. This
fact has also been demonstrated in mouse NIH-3T3 cells over-
expressing human IGF-1R. It is known that KIR-3 is an IGF-
1-mimetic antibody that can induce autophosphorylation of
the IGF-1R, but the kinetics of autophosphorylation even
with a high concentration (100 nM) are slower than those
seen with IGF-1 [36]. This e¡ect was observed in intact cells.
In our experiments, IGF-1R was associated with KIR-3 on the
sensor surface and this binding did not cause autophosphor-
ylation of IGF-1R. In the case of no activation with IGF-1,
the receptor may induce a conformational change by KIR-3
on the sensor surface. It is supposed this conformation change
may result in an increase of the a⁄nity of receptor binding to
IRS-1.
The use of the antibody-capturing approach for receptor^
ligand binding study has certain advantages over the direct
immobilization method on sensor chip surface. Firstly, speci¢c
receptors can be recruited from crude cell lysate without the
need for puri¢ed proteins. The second bene¢t is that the re-
ceptor can be captured in its membrane state, thus preserving
the conformation of the receptor and mimicking the natural
environment of the membrane. As a result, the interaction
between the captured receptor and the ligand can best mimic
the interaction on the cell membrane in vivo. Thirdly, the
capturing of the receptor by speci¢c antibody can provide a
better control of the orientation of the receptor, exposing the
Table 1
The association and dissociation rate constants and a⁄nity constants for IRS-1 binding to IGF-1R with or without IGF-1 activation
IGF-1R ka (M31 s31) kd (s31) KA (M31)
Activated with IGF-1 (5.01 þ 3.35)U106 (6.22 þ 3.26)U1034 (8.06 þ 5.18)U109
Unactivated (5.56 þ 3.66)U105 (5.67 þ 1.60)U1034 (9.81 þ 4.61) U108
Fig. 5. Sensorgrams showing the binding and dissociation pro¢les of IRS-1 with the immobilized IGF-1R from the IGF-1R-overexpressing cells
incubated in (a) the presence of IGF-1 and (b) the absence of IGF-1. The residual plots of the non-linear regression analysis of the association
and the dissociation curves using the one-site binding model (Eqs. 2 and 3) were shown below with the minimum M2 values of the ¢tting. The
experimental data (solid lines) and the ¢tting curves (dotted lines) and the residual plots are shown for three concentrations of IRS-1, (1) 38.2
nM, (2) 19.1 nM, and (3) 3.64 nM, respectively.
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fragment of the receptor with its binding site to the solution
for ligand binding. This approach can be adopted for studies
of the binding between a speci¢c receptor and either its intra-
cellular substrates or its extracellular ligands.
The results obtained in this study clearly demonstrate the
feasibility of using the SPR biosensor assay to obtain quanti-
tative information on the kinetics and thermodynamics of the
binding interactions between cell membrane receptors and
their intracellular and extracellular binding partners.
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